One size does not fit all in severe infection: Obesity alters outcome, susceptibility, treatment, and inflammatory response

Critical Care

Volumn 17, Issue 3, 2013, Pages

  Wacharasint, Petch ^a   Boyd, John H ^a   Russell, James A ^a   Walley, Keith R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN; NORADRENALIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN; AUTACOID;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; COMORBIDITY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SEPTIC SHOCK; AGED; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOUBLE BLIND PROCEDURE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; TREATMENT OUTCOME;

AGED; BODY MASS INDEX; COMORBIDITY; DISEASE SUSCEPTIBILITY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 84879122991     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12794     Document Type: Article

References (30)

1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ, Comparative Risk Assessment Collaborating Group Selected major risk factors and global and regional burden of disease. Lancet 2002, 360:1347-1360. 10.1016/S0140-6736(02)11403-6, 12423980, Comparative Risk Assessment Collaborating Group.
2. Huttunen R, Syrjanen J. Obesity and the outcome of infection. Lancet Infect Dis 2010, 10:442-443. 10.1016/S1473-3099(10)70103-1, 20610324.
3. Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc 2012, 71:298-306. 10.1017/S0029665112000158, 22414338.
4. Huttunen R, Syrjanen J. Obesity and the risk and outcome of infection. Int J Obes (Lond) 2013, 37:333-340.
5. Harrington G, Russo P, Spelman D, Borrell S, Watson K, Barr W, Martin R, Edmonds D, Cocks J, Greenbough J, Lowe J, Randle L, Castell J, Browne E, Bellis K, Aberline M. Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery. Infect Control Hosp Epidemiol 2004, 25:472-476. 10.1086/502424, 15242194.
6. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004, 15:2792-2800. 10.1097/01.ASN.0000141966.69934.21, 15504932.
7. Benson S, Arck PC, Tan S, Mann K, Hahn S, Janssen OE, Schedlowski M, Elsenbruch S. Effects of obesity on neuroendocrine, cardiovascular, and immune cell responses to acute psychosocial stress in premenopausal women. Psychoneuroendocrinology 2009, 34:181-189. 10.1016/j.psyneuen.2008.08.019, 18838227.
8. Habbu A, Lakkis NM, Dokainish H. The obesity paradox: Fact or fiction?. Am J Cardiol 2006, 98:944-948. 10.1016/j.amjcard.2006.04.039, 16996880.
9. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, Kovesdy CP, Younessi H, Anker SD, Morley JE. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 2007, 10:433-442. 10.1097/MCO.0b013e3281a30594, 17563461.
10. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M, ADHERE Scientific Advisory Committee and Investigators An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Herat Failure National Registry. Am Heart J 2007, 153:74-81. ADHERE Scientific Advisory Committee and Investigators.
11. Akinnusi ME, Pineda LA, El Solh AA. Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med 2008, 36:151-158. 10.1097/01.CCM.0000297885.60037.6E, 18007266.
12. Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneil JJ, Ayers D, VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877-887. 10.1056/NEJMoa067373, 18305265, VASST Investigators.
13. Roytblat L, Rachinsky M, Fisher A, Greemberg L, Shapira Y, Douvdevani A, Gelman S. Raised interleukin-6 levels in obese patients. Obese Res 2000, 8:673-675.
14. Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 2001, 175:81-92. 10.1016/S0303-7207(01)00394-X, 11325518.
15. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995, 95:2409-2415. 10.1172/JCI117936, 295872, 7738205.
16. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312. 10.1038/35053000, 11201732.
17. American College of Chest Physicians/Society of Critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874. 10.1097/00003246-199206000-00025, 1597042.
18. Sibbald WJ, Vincent JL. Roundtable conference on clinical trials for the treatment of sepsis. Brussels, march 12-14, 1994. Chest 1995, 107:522-527. 10.1378/chest.107.2.522, 7842788.
19. National Institutes of Health BMI categories. , http://nhlbisupport.com/bmi/
20. Sutherland AM, Walley KR, Manocha S, Russell JA. The association of interleukin 6 haplotype clades with mortality in critically ill adults. Arch Intern Med 2005, 165:75-82. 10.1001/archinte.165.1.75, 15642878.
21. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Hite RD, Harabin AL. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006, 354:2564-2575. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network.
22. Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011, 39:259-265. 10.1097/CCM.0b013e3181feeb15, 20975548.
23. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000, 342:1301-1308.
24. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent J-L, Moreno R, and the Surviving Sepsis Campaign Guidelines Committee including the Pediatric subgroup Surviving sepsis campaign: international guidelines for the management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637. 10.1097/CCM.0b013e31827e83af, 23353941, and the Surviving Sepsis Campaign Guidelines Committee including the Pediatric subgroup.
25. Miller JT, Welage LS, Kraft MD, Alaniz C. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?. J Crit Care 2012, 27:289-293. 10.1016/j.jcrc.2011.06.018, 21855282.
26. Abhyankar S, Leishear K, Callaghan FM, Demner-Fushman D, McDonald CJ. Lower short- and long-term mortality associated with overweight and obesity in a large cohort study of adult intensive care unit patients. Crit Care 2012, 16:R235. 10.1186/cc11903, 3672624, 23249446.
27. Winfield RD, Delano MJ, Cuenca AG, Cendan JC, Lottenberg L, Efron PA, Maier RV, Remick DG, Moldawer LL, Cuschieri J. Obese patients show a depressed cytokine profile following severe blunt injury. Shock 2012, 37:253-256. 10.1097/SHK.0b013e3182449c0e, 22266966.
28. Sunden-Cullberg J, Nystrom T, Lee ML, Mullins GE, Tokics L, Andersson J, Norrby-Teglund A, Treutiger CJ. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med 2007, 35:1536-1542. 10.1097/01.CCM.0000266536.14736.03, 17452927.
29. Gibson JG, Evans WA. Clinical studies of blood volume. I. Clinical application of a method employing the azo dye 'evans blue' and the spectrophotometer. J Clin Invest 1937, 16:301-316. 10.1172/JCI100859, 424872, 16694480.
30. Gregersen MI, Nickerson JL. Relation of blood volume and cardiac output to body type. J Appl Physiol 1950, 3:329-341.